Rxsight (NASDAQ:RXST) specializes in the innovative development of customizable intraocular lenses tailored to improve vision after cataract surgery. A standout in post-operative vision correction, their Light Adjustable Lens technology allows eye care professionals to adjust lens power after implantation, ensuring patients achieve optimal visual outcomes. Rxsight's endeavors aim to revolutionize patient experiences in eye care through groundbreaking adjustable lens technology, striving to meet the unique vision needs of individuals worldwide. The company's dedication is rooted in enhancing quality of life through superior visual acuity, moving beyond traditional approaches to address the dynamic nature of vision correction.